IT Pharma proudly celebrates the arrival of Inbiotec Amber in Argentina, with a dual event that combined science, medical training, and a presentation display worthy of an innovative product with a regenerative soul. The launch of this disruptive skinbuilder has been enthusiastically received by the Argentine medical community, thanks to a carefully curated agenda.
The kick-off took place on April 23rd at the renowned Armenian Center of Buenos Aires, in a pre-congress event that brought together over 150 medical professionals. During this gathering, Inbiotec Amber was introduced, highlighting its powerful antioxidant and anti-inflammatory action, as well as its ability to activate key metabolic pathways involved in skin regeneration.
The event unfolded in a carefully designed atmosphere: with catering, live music, and a stage setup that enhanced the educational and emotional experience, creating a memorable setting that left no one indifferent.
The second stop was held from April 24th to 26th at the prestigious BAAS Congress, one of the most relevant aesthetic medicine events in Latin America. During the gala dinner, Inbiotec Amber was presented to more than 800 doctors in a memorable evening. Attendees learned firsthand about the scientific and clinical foundations that position Inbiotec Amber as a game-changing tool in advanced skin regeneration protocols.
During the congress, our Argentine partner Medicina & Estética offered four practical workshops at their booth, targeting different groups of professionals interested in incorporating Inbiotec Amber into their clinical routines. Medicina & Estética, a committed and dynamic team with a highly competitive portfolio, already distributes Inbiotec in the country and once again showed their enthusiasm to be an active part of the product’s expansion. These workshops allowed attendees to learn in detail about the product’s application protocol and directly address technical questions with the training team.
With outstanding medical participation, highly positive reception, and meticulous organization in every detail, the launch of Inbiotec Amber in Argentina represents a significant milestone for IT Pharma in its international expansion, reaffirming its commitment to scientific innovation in the field of regenerative aesthetics.
